» Articles » PMID: 34029610

Effects of Altered Tau Expression on Dentate Granule Cell Excitability in Mice

Overview
Journal Exp Neurol
Specialty Neurology
Date 2021 May 24
PMID 34029610
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Tauopathies, including Alzheimer's disease, are characterized by progressive accumulation of hyperphosphorylated and pathologic tau protein in association with onset of cognitive and behavioral impairment. Tau pathology is also associated with increased susceptibility to seizures and epilepsy, with tau mice showing seizure resistance in some epilepsy models. To better understand how tau pathology is related to neuronal excitability, we performed whole-cell patch-clamp electrophysiology in dentate gyrus granule cells of tau and human-tau expressing, htau mice. The htau mouse is unique from other transgenic tau models in that the endogenous murine tau gene has been and replaced with readily phosphorylated human tau. We assessed several measures of neuronal excitability, including evoked action potential frequency and excitatory synaptic responses in dentate granule cells from tau, htau, and non-transgenic control mice at 1.5, 4, and 9 months of age. Compared to age matched controls, dentate granule cells from both tau and htau mice had a lower peak frequency of evoked action potentials and greater paired pulse facilitation, suggesting reduced neuronal excitability. Our results suggest that neuronal excitability is more strongly influenced by the absence of functional tau than by the presence of pathologic tau. These results also suggest that tau's effect on neuronal excitability is more complex than previously understood.

Citing Articles

The Bidirectional Relationship Between Epilepsy and Alzheimer's Disease.

Stewart D, Johnson E Curr Neurol Neurosci Rep. 2025; 25(1):18.

PMID: 39921833 DOI: 10.1007/s11910-025-01404-y.


Epilepsy and epileptiform activity in late-onset Alzheimer disease: clinical and pathophysiological advances, gaps and conundrums.

Kamondi A, Grigg-Damberger M, Loscher W, Tanila H, Horvath A Nat Rev Neurol. 2024; 20(3):162-182.

PMID: 38356056 DOI: 10.1038/s41582-024-00932-4.


Progressive Dysregulation of Tau Phosphorylation in an Animal Model of Temporal Lobe Epilepsy.

Concepcion F, Ekstrom N, Khan M, Estes O, Poolos N Neuroscience. 2023; 522:42-56.

PMID: 37142182 PMC: 10330640. DOI: 10.1016/j.neuroscience.2023.04.020.


Deregulated Transcription and Proteostasis in Adult Knockout Mouse.

Andres-Benito P, Flores A, Busquet-Areny S, Carmona M, Ausin K, Cartas-Cejudo P Int J Mol Sci. 2023; 24(7).

PMID: 37047532 PMC: 10095510. DOI: 10.3390/ijms24076559.


Alzheimer's disease and epilepsy: An increasingly recognized comorbidity.

Yang F, Chen L, Yu Y, Xu T, Chen L, Yang W Front Aging Neurosci. 2022; 14:940515.

PMID: 36438002 PMC: 9685172. DOI: 10.3389/fnagi.2022.940515.


References
1.
Jones N, Nguyen T, Corcoran N, Velakoulis D, Chen T, Grundy R . Targeting hyperphosphorylated tau with sodium selenate suppresses seizures in rodent models. Neurobiol Dis. 2011; 45(3):897-901. DOI: 10.1016/j.nbd.2011.12.005. View

2.
Chang Q, Yang H, Wang M, Wei H, Hu F . Role of Microtubule-Associated Protein in Autism Spectrum Disorder. Neurosci Bull. 2018; 34(6):1119-1126. PMC: 6246838. DOI: 10.1007/s12264-018-0246-2. View

3.
Liu S, Zheng P, Wright D, Dezsi G, Braine E, Nguyen T . Sodium selenate retards epileptogenesis in acquired epilepsy models reversing changes in protein phosphatase 2A and hyperphosphorylated tau. Brain. 2016; 139(Pt 7):1919-38. DOI: 10.1093/brain/aww116. View

4.
Fulga T, Elson-Schwab I, Khurana V, Steinhilb M, Spires T, Hyman B . Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo. Nat Cell Biol. 2006; 9(2):139-48. DOI: 10.1038/ncb1528. View

5.
Winokur R, Kubal T, Liu D, Davis S, Smith B . Recurrent excitation in the dentate gyrus of a murine model of temporal lobe epilepsy. Epilepsy Res. 2004; 58(2-3):93-105. DOI: 10.1016/j.eplepsyres.2004.01.002. View